Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
briquilimab
product3 mentionslast seen Nov 9, 2026
An anti-KIT antibody which has demonstrated positive clinical results both as a conditioning agent for stem cell transplant and mast cell mediated diseases such as chronic urticarias and allergic asthma.
Relationships 5
- Jasper Therapeutics, Inc.developsbriquilimab99% confidence3 sources
- briquilimabapplies tomast cell mediated disease treatment88% confidence1 source
- briquilimabapplies tosevere combined immunodeficiencies conditioning88% confidence1 source
- briquilimabapplies tostem cell transplant conditioning88% confidence1 source
- briquilimabapplies tochronic urticaria and allergic asthma treatment88% confidence1 source
Relationship
Jasper Therapeutics, Inc.developsbriquilimab
99% confidence3 supporting mentions
Either name opens that entity’s relationships.
Sources 3
- filingSEC EDGARNov 9, 2026Jasper Therapeutics, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
a pipeline of medicines including vensobafusp alfa, briquilimab
- filingSEC EDGAROct 15, 2026Jasper Therapeutics, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
The company is advancing a pipeline of medicines including vensobafusp alfa, briquilimab, and KP701
- filingSEC EDGAROct 7, 2026Jasper Therapeutics, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
advancing a pipeline of medicines including briquilimab